{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:16:53Z","timestamp":1776896213241,"version":"3.51.2"},"reference-count":87,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,3]],"date-time":"2015-06-03T00:00:00Z","timestamp":1433289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0128080","type":"journal-article","created":{"date-parts":[[2015,6,3]],"date-time":"2015-06-03T18:05:01Z","timestamp":1433354701000},"page":"e0128080","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":84,"title":["Antineuropathic Profile of N-Palmitoylethanolamine in a Rat Model of Oxaliplatin-Induced Neurotoxicity"],"prefix":"10.1371","volume":"10","author":[{"given":"Lorenzo","family":"Di Cesare Mannelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Corti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Boccella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livio","family":"Luongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabatino","family":"Maione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Calignano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Ghelardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,6,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1111\/j.1525-1438.2006.00654.x","article-title":"Clinical application of oxaliplatin in epithelial ovarian cancer","volume":"16","author":"S Fu","year":"2006","journal-title":"Int J Gynecol. Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3816\/CBC.2001.n.022","article-title":"Platinum compounds in the treatment of advanced breast cancer","volume":"2","author":"M Mart\u00edn","year":"2001","journal-title":"Clin Breast Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Multicenter International Study of Oxaliplatin\/5-Fluorouracil\/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"T Andr\u00e9","year":"2004","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/ijc.25369","article-title":"Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil\/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer","volume":"128","author":"M Ducreux","year":"2011","journal-title":"Int J Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00280-007-0454-3","article-title":"Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin","volume":"61","author":"R Petrioli","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/WCO.0b013e3282f1a06e","article-title":"Neurologic complications of chemotherapy agents","volume":"20","author":"G Kannarkat","year":"2007","journal-title":"Curr Op Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.ejca.2008.04.018","article-title":"Chemotherapy induced peripheral neuropathy: prevention and treatment strategies","volume":"44","author":"S Wolf","year":"2008","journal-title":"Eur J Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0093-7754(03)00399-3","article-title":"Oxaliplatin-safety profile: neurotoxicity","volume":"30","author":"A Grothey","year":"2003","journal-title":"Semin Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.2002.07.056","article-title":"Acute oxaliplatin induced peripheral nerve hyperexcitability","volume":"20","author":"RH Wilson","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","article-title":"Chemotherapy-induced peripheral neurotoxicity (CIPN): An update","volume":"82","author":"AA Argyriou","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00520-014-2242-z","article-title":"A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration","volume":"22","author":"AJ Beijers","year":"2014","journal-title":"Support Care Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"A De Gramont","year":"2000","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1200\/JCO.2002.08.015","article-title":"Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial","volume":"20","author":"J Souglakos","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2013.03.019","article-title":"Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: Could it correlate with in vivo neuropathy?","volume":"61","author":"Mannelli L Di Cesare","year":"2013","journal-title":"Free Rad Biol Med"},{"key":"ref15","first-page":"CD005228","article-title":"Intervention for preventive neuropathy caused by cisplatin and related compound","volume":"2","author":"JW Albers","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2008.07558.x","article-title":"Therapy of chemotherapy-induced peripheral neuropathy","volume":"145","author":"TJ Kaley","year":"2009","journal-title":"Br J Haematol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2009.0078","article-title":"NCCN task force report: Management of neuropathy in cancer","volume":"7","author":"MD Stubblefield","year":"2009","journal-title":"J Natl Compr Cancer Netw"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Alliance for Clinical Trials in Oncology. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"EM Smith","year":"2013","journal-title":"JAM"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","article-title":"Control of pain initiation by endogenous cannabinoids","volume":"394","author":"A Calignano","year":"1998","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/jpet.106.111385","article-title":"Rapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-alpha","volume":"319","author":"J LoVerme","year":"2006","journal-title":"J. Pharm Exp Ther."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Di Cesare Mannelli L, D'Agostino G, Pacini A, Russo R, Zanardelli M, Ghelardini C, et al. Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism. Mediators Inflamm. 2013b:328797.","DOI":"10.1155\/2013\/328797"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/npp.2012.25","article-title":"Palmitoylethanolamide protects against the amyloid-\u03b225-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease","volume":"37","author":"G D'Agostino","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1528-1157.2001.41499.x","article-title":"Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice","volume":"42","author":"DM Lambert","year":"2001","journal-title":"Epilepsia"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-2999(96)00015-5","article-title":"N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation","volume":"300","author":"S Mazzari","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s12035-013-8487-6","article-title":"Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator","volume":"48","author":"SD Skaper","year":"2013","journal-title":"Mol Neurobiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1526-4637.2012.01432.x","article-title":"Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis","volume":"13","author":"A Gatti","year":"2012","journal-title":"Pain Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/1876386301205010012","article-title":"New targets in pain, non-neuronal cells, and the role of palmitoylethanolamide","volume":"5","author":"JM Keppel Hesselink","year":"2012","journal-title":"Open Pain J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/JPR.S32143","article-title":"Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series","volume":"5","author":"Hesselink JM Keppel","year":"2012","journal-title":"J Pain Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/IMCRJ.S51572","article-title":"Chronic idiopathic axonal neuropathy and pain, treated with the endogenous lipid mediator palmitoylethanolamide: a case collection","volume":"6","author":"Hesselink JM Keppel","year":"2013","journal-title":"Int Med Case Rep J"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2174\/187152711799219307","article-title":"Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy","volume":"10","author":"A Truini","year":"2011","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0976-500X.72351","article-title":"Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research","volume":"1","author":"C Kilkenny","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/S0959-8049(01)00300-8","article-title":"Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat","volume":"37","author":"G Cavaletti","year":"2001","journal-title":"Eur J Cancer"},{"key":"ref33","first-page":"219","article-title":"Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man","volume":"50","author":"EJ Freireich","year":"1996","journal-title":"Cancer Chemother. Rep."},{"key":"ref34","first-page":"29","article-title":"Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice","volume":"7","author":"CL Renn","year":"2011","journal-title":"Mol Pain"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e102758","DOI":"10.1371\/journal.pone.0102758","article-title":"Oxaliplatin neurotoxicity involves peroxisome alterations. PPAR\u03b3 agonism as preventive pharmacological approach","volume":"9","author":"M Zanardelli","year":"2014","journal-title":"Plos One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1476-5381.1988.tb10310.x","article-title":"k-opioid agonist produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat","volume":"93","author":"GE Leighton","year":"1988","journal-title":"Br J Pharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jpain.2013.08.002","article-title":"Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic Pain","volume":"14","author":"Mannelli L Di Cesare","year":"2013","journal-title":"J Pain"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pain.2009.09.003","article-title":"Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia","volume":"147","author":"M Sakurai","year":"2009","journal-title":"Pain"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00688308","article-title":"The effects of cisaplatin on rat spinal ganglia: a study by light and electron microscopy and morphometry","volume":"69","author":"K Tomiwa","year":"1986","journal-title":"Acta Neuropathol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0165-0270(90)90123-W","article-title":"Calibration of methods for determining numbers of dorsal root ganglia cells","volume":"35","author":"RE Coggeshall","year":"1990","journal-title":"J Neurosci Methods"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3959(02)00296-8","article-title":"Contribution of injured and uninjured dorsal root ganglion neurons to pain behavior and the changes in gene expression following chronic constriction injury of the sciatic nerve in rats","volume":"101","author":"K Obata","year":"2003","journal-title":"Pain"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.expneurol.2006.07.022","article-title":"Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells","volume":"203","author":"CM Peters","year":"2007","journal-title":"Exp Neurol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1523\/JNEUROSCI.21-22-09001.2001","article-title":"Spinal prostaglandins are involved in the development but not the maintenance of inflammation-induced spinal hyperexcitability","volume":"21","author":"E Vasquez","year":"2001","journal-title":"J Neurosci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1744-8069-6-14","article-title":"TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats","volume":"6","author":"S McGaraughty","year":"2010","journal-title":"Mol Pain"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2009.08.013","article-title":"Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids","volume":"148","author":"A Telleria-Diaz","year":"2010","journal-title":"Pain"},{"key":"ref46","first-page":"635","article-title":"Changes in response properties of nociceptive dorsal horn neurons in a murine model of cancer pain","volume":"60","author":"DA Simone","year":"2008","journal-title":"Sheng Li Xue Bao"},{"key":"ref47","article-title":"The Rat Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"1982"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1472-8206.2002.00094.x","article-title":"Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems","volume":"16","author":"L De Petrocellis","year":"2002","journal-title":"Fundam Clin Pharmacol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.NNR.0000289503.22414.79","article-title":"Background noise: The experience of chemotherapy-induced peripheral neuropathy","volume":"56","author":"MA Bakitas","year":"2007","journal-title":"Nurs Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejon.2009.09.005","article-title":"The effect of symptom clusters on functional status and quality of life in women with breast cancer","volume":"14","author":"MJ Dodd","year":"2010","journal-title":"Eur J Oncol Nur"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1007\/s00520-012-1492-x","article-title":"Taxane-induced peripheral neuropathy and healthrelated quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: NSAS BC 02, a randomized clinical trial","volume":"20","author":"K Shimozuma","year":"2012","journal-title":"Support Care Cancer"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jpainsymman.2011.03.017","article-title":"Preliminary assessment of a neuropathic pain treatment and referral algorithm for patients with cancer","volume":"42","author":"EML Smith","year":"2011","journal-title":"J Pain Symptom Manage"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1089\/jpm.2010.0124","article-title":"Surviving chemotherapy for colon cancer and living with the consequences","volume":"13","author":"C Tofthagen","year":"2010","journal-title":"J Palliat Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/S0959-8049(02)00229-0","article-title":"Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity","volume":"38","author":"G Cavaletti","year":"2002","journal-title":"Eur J Cancer"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/clpt.2011.115","article-title":"Chemotherapy-induced peripheral neuropathy: Prevention and treatment","volume":"90","author":"DR Pachman","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"American Society of Clinical Oncology. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"DL Hershman","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/annonc\/mdu107","article-title":"Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT","volume":"25","author":"HS Hochster","year":"2014","journal-title":"Ann Oncol"},{"key":"ref58","first-page":"342","article-title":"Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model","volume":"46","author":"J Holmes","year":"1998","journal-title":"Toxicol Sci"},{"key":"ref59","first-page":"2437","article-title":"Morphological and electrophysiological study of the effects of cisplatin and ORG2766 on rat spinal ganglia neurons","volume":"50","author":"LJ Muller","year":"1990","journal-title":"Cancer Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pain.2009.09.030","article-title":"Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury","volume":"147","author":"SM Carlton","year":"2009","journal-title":"Pain"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1871527311312010009","article-title":"Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial\/microglial phenotypical changes in mice","volume":"12","author":"L Luongo","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrn1700","article-title":"Role of the immune system in chronic pain","volume":"6","author":"F Marchand","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"J Scholz","year":"2007","journal-title":"Nat Neurosci"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s00018-007-6494-3","article-title":"The innate immunity of the central nervous system in chronic pain: the role of Toll-like receptors","volume":"64","author":"LH Guo","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/glia.22415","article-title":"Minocycline and fluorocitrate suppress spinal nociceptive signaling in intrathecal IL-1\u03b2-induced thermal hyperalgesic rats","volume":"60","author":"CS Sung","year":"2012","journal-title":"Glia"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1158\/1078-0432.CCR-04-1807","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin,and carboplatin in nonhuman primates","volume":"11","author":"SS Jacobs","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00280-009-1085-7","article-title":"Extracellular fluid concentrations of cisplatin, carboplatin and oxaliplatin in brain, muscle and blood measured using microdialysis in nonhuman primates","volume":"65","author":"SS Jacobs","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2014.06.016","article-title":"Glial role in oxaliplatin-induced neuropathic pain","volume":"261","author":"Mannelli L Di Cesare","year":"2014","journal-title":"Exp Neurol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.bbi.2011.02.006","article-title":"Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cordinjury","volume":"25","author":"E Esposito","year":"2011","journal-title":"Brain Behav Immun"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Di Cesare Mannelli L, Corti F, Micheli L, Zanardelli M, Ghelardini C. Delay of morphine tolerance by Palmithoylethanolamide. Biomed Res Int. 2014b: Article ID894732.","DOI":"10.1155\/2015\/894732"},{"key":"ref71","first-page":"138","article-title":"Strategies to increase the activity of microglia as efficient protectors of the brain against infections","volume":"8","author":"R Nau","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrn2533","article-title":"Pathological and protective roles of glia in chronic pain","volume":"10","author":"ED Milligan","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cyto.2014.06.004","article-title":"The effects of protein malnutrition on the TNF-RI and NF-\u03baB expression via the TNF-\u03b1 signaling pathway","volume":"69","author":"DC de Oliveira","year":"2014","journal-title":"Cytokine"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14728222.2012.680955","article-title":"Targeting pain mediators induced by injured nerve-derived COX2 and PGE2 to treat neuropathic pain","volume":"16","author":"W Ma","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phrs.2013.07.007","article-title":"N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress","volume":"76","author":"Raso G Mattace","year":"2013","journal-title":"Pharmacol Res"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jpain.2011.11.009","article-title":"Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin","volume":"13","author":"Mannelli L Di Cesare","year":"2012","journal-title":"J Pain"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.1523\/JNEUROSCI.23-21-07767.2003","article-title":"Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility","volume":"23","author":"A Franklin","year":"2003","journal-title":"J Neurosci"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2826.2011.02152.x","article-title":"Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-\u03b1","volume":"23","author":"Raso G Mattace","year":"2011","journal-title":"J Neuroendocrinol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pain.2011.08.010","article-title":"Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain","volume":"153","author":"O Sasso","year":"2012","journal-title":"Pain"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"E298","DOI":"10.1208\/aapsj080234","article-title":"Cannabinoid receptors and endocannabinoids: evidence for new players","volume":"8","author":"K Mackie","year":"2006","journal-title":"AAPS J"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/sj.bjp.0704732","article-title":"\u2018Entourage\u2019 effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide induced vanilloid receptor activation and upon anandamide metabolism","volume":"136","author":"D Smart","year":"2002","journal-title":"Brit J Pharmacol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.phrs.2012.10.013","article-title":"Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment","volume":"67","author":"J Guindon","year":"2013","journal-title":"Pharmacol Res"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1523\/JNEUROSCI.0403-12.2012","article-title":"Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy","volume":"32","author":"IA Khasabova","year":"2012","journal-title":"J Neurosci"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj3580249","article-title":"Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells","volume":"358","author":"V Di Marzo","year":"2001","journal-title":"Biochem J"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2407-12-92","article-title":"The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action","volume":"12","author":"L Hamtiaux","year":"2012","journal-title":"BMC Cancer"},{"key":"ref86","first-page":"11","article-title":"Studies on prophylactic efficacy of N-2-hydroxyethyl palmitamide (Impulsin) in acute respiratory infections. Serologically controlled field trials","volume":"23","author":"R Kahlich","year":"1979","journal-title":"J Hyg Epidemiol Microbiol Immunol"},{"key":"ref87","first-page":"151028","article-title":"Palmitoylethanolamide: a natural body-own anti-inflammatory agent, effective and safe against influenza and common cold","volume":"2013","author":"Hesselink JM Keppel","year":"2013","journal-title":"Int J Inflam"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0128080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T20:43:53Z","timestamp":1652215433000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0128080"}},"subtitle":[],"editor":[{"given":"Theodore John","family":"Price","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,3]]},"references-count":87,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0128080","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,3]]}}}